Speakers 2007

19 leading professionals from the Nordic countries.
Anders Haugland
Managing director of Bergen Teknologioverføring AS, Norway. His previous position was research manager at Sintef Energy Research AS, Trondheim. Phd from The Norwegian University of Science and Technology.
Cand. Pharm. Ph.d., Director of the GCP-unit at Aarhus University Hospital, Denmark. The GCP-unit is a public contract research organization offering researchers monitoring of clinical trials and guidance about the principles of Good Clinical Practice. The unit was established in 1995 and was the first public GCP-unit in Denmark. Annette Jørgensen played a central role in this process. Today the unit is involved in monitoring of more than 100 trials.
Senior consultant in intensive care medicine, Haukeland University Hospital and Associate Professor Dept. of Surgical Sciences, Section of Anaesthesiology an intensive care, University of Bergen, Norway. Main scientific interest: Anaphylaxis during anaesthesia and how to implement clinical research into daily practice.
Clinical research physician at the "The Paediatric clinical research centre", which will be opened during spring at Haukeland University Hospital, Bergen, Norway. This is probably the first research centre solely for children in the Nordic countries.
Bjarne Bjorvatn was professor of medicine (international health) at the University of Bergen and senior consultant (microbiology, infectious diseases) at Haukeland University Hospital until he in 2002 entered the current WHO contract as co-ordinator for the development of official WHO policies on the use of vaccines. Bjorvatn has extensive experience of international research collaboration, including several EC sponsored projects.
Since 1992, Birgitta Åsjö is professor of Virology/HIV-AIDS at the Medical Faculty, University of Bergen, Norway. Her research areas are within HIV pathogenesis, biological properties of HIV, virus-host cell interaction and also the combinatorial effects of HIV and Mycobacterial infections. She was involved in the first phase I trial of a Norwegian therapeutic HIV vaccine.
Heads the Department of Research Administration at The Tampere University Hospital, Finland. Today the department handles about 1600 running scientific projects.
He has extensive experience in clinical research management in pharmaceutical industry towards international standards in several countries.
Also speaker at NRC 2006 and now a Member of NRC Faculty.
Giuseppe V. Masucci is Professor at the Karolinska Institute, Sweden, Institute for Oncology-Pathology and consultant in oncology at the Oncological clinic, Karolinska University Hospital in Stockholm. He is coordinator for the Nordic Centre of Excellence for anticancer Vaccines (NCEV) and is Associate Editor for the Scientific Journal “Medical Oncology”.
Hans Gregersen, Research Director at Aalborg Hospital in Denmark. In addition to the medical degree he holds a degree in strategic management. He played a central role in the process for Aalborg Hospital towards the status as a university hospital. A research organisation was build up in a short time period to serve the hospital.
Professor University of Bergen, Norway, adjunct position Division of Psychiatry, Haukeland University Hospital. Head of the Bergen fMRI-group, which is part of the Strategic Research Programme Haukeland University Hospital, and the Bergen Mental Health Research Center. Member of Nordic Center of Excellence in Cognitive Control and functional neuroimaging.

Lars R. Haaheim
Professor Lars R. Haaheim is heading the Influenza Centre, The Gade Institute, University of Bergen, Norway. In the earlier phases of his career Haaheim was deeply involved and responsible for the production of influenza vaccines in Norway (Norwegian Institute of Public Health, Osl

Lars Nyberg
Previously Professor of Psychology and Neuropsychology and now Professor of neuroscience (Radiation sciences & Integrative Medical Biology) Umeå University, Sweden. Multiple publications concerning Functional Brain Imaging

Mika Scheinin
Mika Scheinin is Professor of Pharmacology and Chair of the Department of Pharmacology, Drug Development and Therapeutics at the University of Turku, Finland. He is also Director of Clinical Research Services Turku (CRST), a university-based clinical contract research unit, and Chairman of the Ethics Committee of South-West Finland Health Care District. His main scientific interest is neuropharmacology.

Ole-Erik Iversen
Professor Womens Clinic, Haukeland University Hospital, Bergen, Norway. National coordinator for several HPV-vaccination studies, member of the International Steering Committee of the FUTURE studies. He also held a speach at last years conference: "Vaccination against cancer?". This year he will give us the exiting results, and some of the questions for the way forward.

Roland Jonsson
DMD, PhD, Head of the Broegelmann Research Laboratory and Professor (the Broegelmann Chair in Immunology) at the Gade Institute, University of Bergen (http://www.uib.no/Broegelmann/) with affiliations at the Departments of Rheumatology and Oto-Rhino-Laryngology/Head and Neck Surgery, Haukeland University Hospital, Norway. The scientific bibliography consists mainly of translational studies in autoimmunity (Sjögren’s syndrome and other rheumatic diseases).

Stig Gunnar Olof Johansson
Professor in Clinical Immunology, Karolinska Institute, Stockholm, Sweden, 1980 – 2005. Nominated discoverer of IgE, World Health Organization, February 1968. He has published more than 400 peer-reviewed publications within the field of allergy and clinical immunology.
Stina Gestrelius
Deputy Managing Director of Medicon Valley Academy, Sweden. Stina Gestrelius, Dr Sc (biotechnology) had extensive experience from preclinical and clinical R&D in pharmaceutical companies before starting the successful Swedish biotech company Biora AB in Malmö in 1988.

Stina Gestrelius

Deputy Managing Director of Medicon Valley Academy, Sweden. Stina Gestrelius, Dr Sc (biotechnology) had extensive experience from preclinical and clinical R&D in pharmaceutical companies before starting the successful Swedish biotech company Biora AB in Malmö in 1988. Stina Gestrelius is currently a member of multiple boards at the Univesity of Lund and pharmaceutical companies.

Theresa L. Whiteside
Ph.D., Professor of Pathology, Immunology and Otolaryngology, University of Pittsburgh School of Medicine, Laboratory Director, Immunologic Monitoring and Cellular Products Laboratory, University of Pittsburgh Cancer Institute, Pennsylvania, USA. She is a recognized expert in immune monitoring of patients with cancer. She has authored 417 peer-reviewed publications in scientific journals and 105 chapters/review articles.

Vilhjálmur Árnason
Professor Vilhjálmur Árnason is Chair of the Department of Philosophy and Chair of the Centre for Ethics, University of Iceland. Chair of the Nordic Bioethics Committee and boardmember of The European Society for Philosophy of Medicine and Health Care (2007). He has published widely in ethics and social philosophy.
Last Updated ( Wednesday, 02 December 2009 )